22nd Century Group Investor Relations Material
Latest events
Q4 2023
22nd Century Group
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from 22nd Century Group Inc
Access all reports
22nd Century Group, Inc., is an agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. The Company has a corporate mission to produce tobacco harm reduction products. The Company also intends to develop proprietary research tools with applications in wheat grain quality enhancement and development of genetically-modified cultivars for the biofuels industry. Target markets for these products include cigarette smokers who want to decrease their risk of tobacco related disease; adult smokers who will switch to less harmful alternatives; and switching from cigarettes or other harmful products to lower risk alternatives like e-cigarettes.
Key slides for 22nd Century Group Inc
Q1 2023
22nd Century Group Inc
Q1 2023
22nd Century Group Inc
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States